Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam
- 13 February 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (3) , 411-412
- https://doi.org/10.1212/wnl.56.3.411
Abstract
Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury—the degree of functional improvement may depend on the severity of associated motor dysfunction.Keywords
This publication has 5 references indexed in Scilit:
- Physiology of human posthypoxic myoclonusMovement Disorders, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profilesEpileptic Disorders, 2000
- Revisiting the Concept of Identifiable NeuronsBrain, Behavior and Evolution, 2000
- Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystoniaEuropean Journal of Pharmacology, 2000